99 related articles for article (PubMed ID: 2105703)
21. Ablative free thyroxine to thyroglobulin ratio as a predictor of differentiated thyroid cancer recurrence.
Aron M; Cote V; Tamilia M; Hier M; Black MJ; Zhang X; Payne RJ
J Otolaryngol Head Neck Surg; 2009 Oct; 38(5):552-8. PubMed ID: 19769825
[TBL] [Abstract][Full Text] [Related]
22. Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.
Gibelli B; Tredici P; De Cicco C; Bodei L; Sandri MT; Renne G; Bruschini R; Tradati N
Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):94-9. PubMed ID: 16116831
[TBL] [Abstract][Full Text] [Related]
23. [Basic policy for postsurgical follow-up of patients with differentiated thyroid carcinoma--guidelines from abroad].
Hamada N
Nihon Rinsho; 2007 Nov; 65(11):2061-7. PubMed ID: 18018571
[TBL] [Abstract][Full Text] [Related]
24. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
Abduluakhab M; Gavrilov M; Mladenov B
Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
[TBL] [Abstract][Full Text] [Related]
25. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid].
Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J
An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622
[No Abstract] [Full Text] [Related]
26. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
[TBL] [Abstract][Full Text] [Related]
27. Follow-up of thyroid cancer patients with favorable prognostic indicators.
Leboulleux S; Baudin E; Schlumberger M
Ann Endocrinol (Paris); 2003 Feb; 64(1):64-7. PubMed ID: 12707639
[No Abstract] [Full Text] [Related]
28. [Thyroglobulin, 131I-whole body scintigraphy and risk factors in the follow-up of differentiated thyroid cancer].
Berding G; Hüfner M; Georgi P
Nuklearmedizin; 1992 Feb; 31(1):32-7. PubMed ID: 1561118
[TBL] [Abstract][Full Text] [Related]
29. Current approaches to the treatment of well-differentiated thyroid cancer.
Angelos P
Oncology (Williston Park); 2002 Mar; 16(3):309-15; discussion 315, 318, 323-4. PubMed ID: 15046390
[TBL] [Abstract][Full Text] [Related]
30. Serum thyroglobulin and whole-body iodine-131 scan in the management of differentiated thyroid carcinoma.
Klein HA
J Nucl Med; 1991 Aug; 32(8):1645. PubMed ID: 1869997
[No Abstract] [Full Text] [Related]
31. Imaging surveillance of differentiated thyroid cancer.
Johnson NA; LeBeau SO; Tublin ME
Radiol Clin North Am; 2011 May; 49(3):473-87, vi. PubMed ID: 21569906
[TBL] [Abstract][Full Text] [Related]
32. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
33. [Long-term observation of 15 patients with differentiated thyroid cancer and elevated plasma thyroglobulin levels of unclear origin].
Stumpf HP; Hüfner M; Hermann HJ; Kimmig B
Klin Wochenschr; 1984 May; 62(9):417-22. PubMed ID: 6727283
[TBL] [Abstract][Full Text] [Related]
34. [The characteristics of the clinical course and therapy of thyroid cancer in children].
Rozdil'skiĭ SI; Afanas'eva NI; Nachinova NA; Tkachenko GI; Astap'eva ON; Vasil'ev LIa; Duma VA
Ter Arkh; 1992; 64(10):55-8. PubMed ID: 1485257
[No Abstract] [Full Text] [Related]
35. The usefulness of serum thyroglobulin in the follow-up of differentiated thyroid carcinoma in children.
Kirk JM; Mort C; Grant DB; Touzel RJ; Plowman N
Med Pediatr Oncol; 1992; 20(3):201-8. PubMed ID: 1574029
[TBL] [Abstract][Full Text] [Related]
36. [Differentiated thyroid carcinoma: initial evaluation and follow-up].
Golbert L; Wajner SM; Rocha AP; Maia AL; Gross JL
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):701-10. PubMed ID: 16444352
[TBL] [Abstract][Full Text] [Related]
37. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management.
Giovanella L
Clin Chem Lab Med; 2008; 46(8):1067-73. PubMed ID: 18605946
[TBL] [Abstract][Full Text] [Related]
38. Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?
Murray JR; Williams GR; Harrington KJ; Newbold K; Nutting CM
Clin Endocrinol (Oxf); 2012 Jul; 77(1):155-7. PubMed ID: 22171652
[No Abstract] [Full Text] [Related]
39. Serum thyroglobulin in the management of patients with thyroid cancer.
Barsano CP; Skosey C; DeGroot LJ; Refetoff S
Arch Intern Med; 1982 Apr; 142(4):763-7. PubMed ID: 7073416
[TBL] [Abstract][Full Text] [Related]
40. Scintigraphic evaluation of patients with thyroid carcinoma--therapeutic approaches.
Krausz Y; Uziely B; Lijovetsky G; Isacson R; Levinger E; Catane R; Karger H; Atlan H
Isr J Med Sci; 1992; 28(3-4):206-11. PubMed ID: 1592589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
